Skip to main content
Health

BAT Impact RCT

Food allergy affects approximately 8% of children and can substantially impair quality of life through dietary restrictions, anxiety, and the risk of severe allergic reactions. Accurate diagnosis is therefore essential. Oral food challenges (OFCs) remain the gold standard for diagnosing food allergy but are resource intensive, can provoke allergic reactions, and are associated with significant anxiety for children and families.

The BAT Impact Study is a UK multicentre randomised controlled trial investigating whether incorporation of the Basophil Activation Test (BAT), and subsequently the Mast Cell Activation Test (MAT), into the diagnostic pathway can improve the safety and efficiency of food allergy diagnosis in children and young people.

BAT is a blood-based functional assay that measures allergen-induced activation of basophils by flow cytometry. Previous studies have demonstrated excellent diagnostic accuracy and shown that BAT can substantially reduce the need for positive oral food challenges.

Children aged 6 months to 15 years with suspected allergy to peanut, cow’s milk, egg, sesame, or cashew are enrolled across ten specialist allergy centres in the UK. Participants are randomised to either standard diagnostic care or a biomarker-guided strategy using BAT. In the biomarker arm, participants with positive BAT results may avoid an oral food challenge, while those with negative or inconclusive results proceed to challenge testing.

The study evaluates whether biomarker-guided diagnosis reduces allergic reactions during oral food challenges while maintaining diagnostic accuracy and improving patient experience. Additional outcomes include quality of life, anxiety, health-economic impact, and validation of BAT, MAT, and diagnostic algorithms for food allergy.

Team Members at other sites:

  • Professor Graham Roberts (Southampton)
  • Dr Vibha Sharma (Manchester)
  • Professor Jürgen Schwarze (Edinburgh)
  • Dr Nick Makwana (Birmingham)
  • Dr Zaraquiza Zolkipli (Cambridge)
  • Dr Gary Stiefel (Leicester)
  • Dr Penny Salt (UCLH - London)
  • Dr Louise Jane Michaelis (Newcastle)
  • Dr Eleanor Minshall (Sheffield)
  • Dr George Raptis (Glasgow)
  • Dr Lavanya Diwakar (Birmingham – Health Economics)

Aims

  • Determine whether incorporating BAT into the diagnostic work-up reduces allergic reactions occurring during oral food challenges.
  • Compare the number of oral food challenges required to diagnose food allergy in each arm.
  • Assess the impact of diagnostic testing on quality of life and anxiety in children and their families.
  • Evaluate the cost-effectiveness of introducing BAT and MAT into routine diagnostic pathways.
  • Validate the diagnostic accuracy of BAT, MAT, skin prick testing, specific IgE testing, and integrated diagnostic algorithms.

Methods

A prospective multicentre biomarker-led randomised controlled trial conducted across ten UK paediatric allergy centres. Children aged 6 months to 15 years with suspected allergy to peanut, milk, egg, sesame, or cashew requiring an oral food challenge are randomised to standard care or a BAT-guided diagnostic strategy. Participants undergo clinical assessment, skin prick testing, health economics, quality-of-life and anxiety (STAI, RCADS, HADS, BTMS, BMI-C) questionnaires at baseline and ca. 2 months after diagnosis, and collection of blood samples for specific IgE testing, BAT and MAT. Oral food challenge outcomes, health-economic measures, and patient-reported outcomes are compared between groups.

Trials Design

  • Multicentre (8 sites) parallel-group randomised controlled trial using a biomarker-strategy design.
  • Participants are randomised between standard-of-care and BAT-guided diagnostic pathways (randomisation 4:5, stratified at each site using a web-based system).
  • Primary outcome is the proportion of positive oral food challenges in each study arm.

Registration: ClinicalTrials.gov NCT05309772; IRAS 299511; REC 22/LO/0903

Protocol (attached).

Summary of Findings

Recruitment has been completed with 251 participants enrolled across participating UK centres. Data cleaning and statistical analyses are underway. Results are not yet available.

Impact

The study aims to transform food allergy diagnosis by reducing the number of allergic reactions experienced during oral food challenges, decreasing reliance on challenge testing, improving patient experience, reducing anxiety, and increasing diagnostic efficiency. If successful, BAT-guided diagnosis could provide a safer, more cost-effective, and patient-centred approach to diagnosing food allergy in children.

Project status: Ongoing
BAT impact logo

Principal Investigator

Investigators

Funding

Funding Body: Food Allergy Research & Education

Amount: $500,000

Period: June 2022 - December 2027